Human autoimmune disease
POPULARITY
Categories
There are mothers… and then there are matriarchs. This week in the Den, we sit down with Donna Jordan — lifelong visual artist, educator, proud grandmother, mother of three — and yes, the mother of Michael B. Jordan. But this conversation? It's about her. Donna shares what it really looked like to raise three creative children while nurturing her own artistry — creating art between caregiving and callbacks working in hand-painted silk and design to help support her family, and making sure her children saw her creating even when life was full. She opens up about being diagnosed with lupus in 1997, navigating fear and uncertainty, and “faking it” through pain so her children wouldn't carry the weight of her illness. She talks about what it means to mother through invisible disease, to show up when your body doesn't want to, and how watching her push through shaped her children's empathy and work ethic. And now? We see the fruit. Her children don't just succeed — they show up. They place her art on sets. They manage her business. They honor her publicly. They protect the woman she is and the legacy she built quietly for decades. This episode is about reciprocity. About raising children who return the love. About taking your “$10” for yourself. About reclaiming your time — at any age. If you've ever wondered whether your sacrifices matter… this one will sit with you. Keep up with Donna Jordan on IG: @dj_kree8tive The Mamas are building our community and ways to keep in touch with you. Share your email address here: https://tinyurl.com/MamasDen Make sure you connect with our Mamas on IG: @themamasdenpodcast Ashley - @watermeloneggrolls Codie - @codieco Melanie - @melaniefiona Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
What happens when an Infectious Disease specialist and a Rheumatologist look at the same gut?
This content is for informational and entertainment purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.----------------------------------------For decades, lupus has remained one of the most complex challenges in modern medicine. Its extreme heterogeneity, where symptoms and triggers can vary widely from one patient to the next, has made the disease difficult to study, diagnose, and treat.As a result, lupus has often been passed over by traditional venture capital in favor of conditions with more predictable development paths.That dynamic is now beginning to change.A growing wave of scientific advances, regulatory progress, and an increasingly active clinical pipeline is signaling a turning point for millions of patients worldwide.At the center of this shift is Lupus Ventures, a mission driven investment fund launched by the Lupus Research Alliance.The fund combines the discipline of life sciences venture capital with a clear focus on return on mission, aiming to close the funding gap that has long stalled promising breakthroughs in autoimmune disease research.In this spotlight, we speak with Nishant Rastogi, Managing Director of Lupus Ventures.Drawing on more than a decade of experience in biotech private equity and venture capital, Nishant explains why he chose to lead a mission driven fund, why early diagnostics are critical to improving patient outcomes, and how Lupus Ventures is helping reshape how cures are funded for historically underserved diseases.Full interview ----------------------------------------Investing in Impact is powered by Causeartist, a nonprofit media company dedicated to bridging the gap between capital and culture by spotlighting founders, investors, and organizations reimagining how business can serve people and the planet.Through storytelling, events, and open-access education, Causeartist helps create a shared language of impact, inspiring more founders to build with purpose and more funders to invest with intention.By amplifying ideas and innovations across industries, Causeartist transforms awareness into action and cultivates a community where paying it forward is part of the foundation for growth.
After my own autoimmune journey, I'm always inspired by stories of rapid healing. Wendy Presant went from struggling with dry eyes, fatigue, and joint pain to seeing major improvements in just two weeks on the Autoimmune Protocol. What struck me most was her message about protecting our kids: only 30% of autoimmune risk is genetic, meaning we can actually change our children's trajectory. She breaks down the gut-microbiome connection, shares which nutrient deficiencies directly cause symptoms like dry eyes, and gives you practical tools you can start using today. Whether you're dealing with Sjogren's or any autoimmune condition, Wendy's spider web analogy will change how you think about managing your health. For the complete show notes, links and transcripts, visit inspiredliving.show/232
In today's episode, I sit down with JJ Barrows, author, artist, and Dry Bar comedian, for a conversation about why humor might just be the most underrated healing tool we have. JJ is a deep-feeler who has found a way to make comedy out of the hard stuff, and this episode is proof that laughter and honesty go hand in hand.We get into JJ's unexpected email collaboration with Dolly Parton (which she was completely convinced was a scam), her handmade egg-carton crowns and what they're really about, and our shared love of extra accessories. We also get real about depression, anxiety, eating disorders, and my own experience with Lupus, and why finding the funny doesn't mean pretending everything is fine.Episode Timeline Highlights[00:00] – Introduction[04:02] – The secret Dolly Parton email: Why JJ was convinced she was being scammed until she heard the unreleased track.[08:26] – Calling a spade a spade: Breaking the "everything is fine" facade to talk about depression and recovery.[12:06] – Why comedy is more than just jokes: Using humor as a tool to take a breather from the tough stuff in the world.[15:19] – Unexpected therapy: The calming power of smelling a baby's head and why I talk to my chickens over the fence.[19:45] – The Crafting Queen: How JJ's egg-carton crowns are actually about giving other people their "golden buzzer" moment.[31:34] – Becoming fearless at 70: How facing mortality erased my stage fright and why I'll talk to anyone now.[46:23] – The secret to a great act: Why you owe it to your audience to do what they find funny, not just your own agenda.Connect With Us:Follow JJ Barrows on Instagram @ jjbarrowsJJ Barrows Official Website: jjbarrows.comJJ's Books: 'A Spade a Spade' and 'Kind of Funny'Watch JJ's Dry Bar Comedy Special on YouTubeFinal Thoughts:Thank you for tuning in for this one. If you enjoyed this episode, please like, subscribe, and share it with a friend who could use a good laugh.
If you're struggling with brain fog, chronic fatigue, or autoimmune symptoms, this conversation might completely shift how you think about your body's detox system. In it, I sit down with Dr. Gina Nick to discuss why glutathione - our master antioxidant - is absolutely crucial for managing inflammation and autoimmune conditions. We dive deep into why most people need extra glutathione support, how brain fog and anxiety are often neuroinflammation in disguise, and simple daily actions you can take to support your body's natural detox system. This isn't about expensive IV treatments - it's about giving your body the physiologic support it needs to handle our modern world. ***Disclaimer: As an affiliate, I may earn from qualifying purchases made through the links in this episode.***For the complete show notes, links and transcripts, visit inspiredliving.show/231
Your weekly report from Abobolandia is here, it's hot, and it's served up fresh with a heavy dollop of snark. The attacks on the abortion pill mifepristone continue. HHS just said pharmacies don't have to stock abortion pills anymore. Cool cool cool. Totally normal functioning democracy stuff.Meanwhile, manufacturers of the pill are gearing up to fight what could become a national telehealth abortion ban, and for once we're actually rooting for Big Pharma. We won't make it a thing, we promise. GUEST ROLL CALL:Moji and Lizz sit down with Amy Hagstrom Miller, President & CEO of Whole Woman's Health, who is providing telehealth abortion care in 10 states while the federal government plays regulatory roulette with people's bodies. Independent clinics still provide the majority of abortion care in this country. Yes, indie clinics, not hospital systems, not corporations, and they are being squeezed from every direction. Then musician and activist Gwen Levey pulls up to talk to Moji about using her voice loudly in a moment when silence is complicity, and especially as the DOJ refuses to meaningfully pursue accountability for the victims of Jeffrey Epstein. Her video, “Barefoot & Pregnant,” recently went viral for highlighting the atrocities of Project 2026. Institutions bending over backwards for predators and cracking down on bodily autonomy is all part of their plan. But never, fear! We have the info you need and the tools to fight back.Times are heavy, but knowledge is power, y'all. We gotchu. OPERATION SAVE ABORTION: You can still join the 10,000+ womb warriors fighting the patriarchy by clicking HERE to for past Operation Save Abortion trainings, your toolkit, marching orders, and more.HOSTS:Lizz Winstead IG: @LizzWinstead Bluesky: @LizzWinstead.bsky.socialMoji Alawode-El IG: @Mojilocks Bluesky: @Mojilocks.bsky.socialSPECIAL GUESTS:Amy Hagstrom Miller IG: @wholewomans @wwhallianceGwen Levey IG: @gwenleveymusic @riseabovejusticemovementGUEST LINKS:Whole Woman's HealthWhole Woman's Health Virtual ServicesWhole Woman's Health Alliance LinktreeDONATE: Whole Woman's HealthDONATE: Whole Woman's Health Alliance Gwen Levey Linktree“Barefoot & Pregnant” Exposes Project 2026 in Viral VideoRise Above Justice Movement WebsiteRise Above Justice Movement LinktreeRise Above Justice Movement PodcastNEWS DUMP:HHS Will Allow Pharmacies to Boycott Lifesaving Drugs Used in Medication AbortionMifepristone Manufacturers Move to Block GOP Lawsuit Seeking Nationwide Telehealth Abortion BanIndependent Clinics Still Provide Most U.S. AbortionsEPISODE LINKS:TICKETS: Michael Shannon & Jason Narducy TourBUY: Michael Shannon & Jason Naruducy 2026 Tour PosterADOPT-A-CLINIC: Whole Woman's Health of MinnesotaOperation Save AbortionExpose Fake ClinicsBUY AAF MERCH!EMAIL your abobo questions to The Feminist BuzzkillsAAF's Abortion-Themed Rage PlaylistFOLLOW US:Listen to us ~ FBK Podcast Instagram ~ @AbortionFrontBluesky ~ @AbortionFrontTikTok ~ @AbortionFrontFacebook ~ @AbortionFrontYouTube ~ @AbortionAccessFrontTALK TO THE CHARLEY BOT FOR ABOBO OPTIONS & RESOURCES HERE!PATREON HERE! Support our work, get exclusive merch and more! DONATE TO AAF HERE!ACTIVIST CALENDAR HERE!VOLUNTEER WITH US HERE!ADOPT-A-CLINIC HERE!GET ABOBO PILLS FROM PLAN C PILLS HERE!When BS is poppin', we pop off! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Send a textNishant Rastogi is the inaugural Managing Director of Lupus Ventures ( https://www.lupusventures.org/ ), the venture investment fund of the Lupus Research Alliance ( LRA - https://www.lupusresearch.org/ ), where he serves on the Investment Committee. In this role, he leads all aspects of the fund — from sourcing and evaluating opportunities to structuring deals and managing the portfolio — while overseeing team recruitment, business development, and coordination with the fund's Investment Committee and Scientific Advisory Board.Lupus Ventures is the world's only venture fund dedicated to systemic lupus erythematosus (SLE) and related autoimmune conditions. It aims to accelerate the development of new therapies and diagnostics that improve care and deliver meaningful impact for the millions of people living with lupus worldwide.A seasoned life sciences investor with over a decade of experience in venture capital and private equity, Mr. Rastogi has served as a Board Director and operating partner for multiple biotech and medtech companies. Prior to Lupus Ventures, he was Vice President and Head of Transactions at New Rhein Healthcare Investors, where he helped establish the firm's U.S. office, executed transactions across diverse therapeutic areas, and managed a portfolio totaling over $200 million in direct investments. His work spanned financing, clinical development, regulatory strategy, manufacturing, and commercialization. Notable investments include Corsair, Theranica, Alveus, American Injectables, Butterfly Medical, Softhale, EirCor, and Neuraptive.Earlier in his career, Mr. Rastogi was a founding associate at Broadview Ventures, a Boston-based venture capital fund focused on cardiovascular innovation, and has advised multiple disease research foundations — including Beyond Celiac and Parent Project Muscular Dystrophy — on venture fund formation and the intersection of philanthropy and private investment in advancing medicines and health equity. He began his career as an analyst at Fidelity Investments.Mr. Rastogi holds a B.A. in Economics and Mathematical Finance from Dartmouth College, an MBA from Northwestern University (Kellogg), a Medical Science Certificate from Harvard, and a Certificate in Climate Change and Health from Yale.#Lupus #AutoimmuneDisease #LupusResearch #BiotechInnovation #Immunology #HealthcareInnovation #PrecisionMedicine #WomensHealth #HealthEquity #VentureCapital #Biotechnology #SystemicLupus #LupusAwareness #MedicalBreakthrough #LifeSciencesSupport the show
I've been helping people with autoimmunity for years, but since 2020, I'm seeing more overlap with chronic fatigue and long COVID than ever before. That's why I brought Dr. Evan Hirsch on the show - he's the EnergyMD who's cracked the code on why 99% of these cases have the same root causes. What he reveals about who actually gets long COVID will surprise you. We dive into his "Toxic Five" framework, why your lab work might be normal but you still feel terrible, and his four-step recovery method that's helping people reclaim their energy in 6-12 months. If you're exhausted despite "normal" test results, this conversation is for you.For the complete show notes, links and transcripts, visit inspiredliving.show/230
Unraveling LupusSUMMARY: Lupus isn't just a butterfly rash—it's an autoimmune overdrive that can touch almost every organ system. In this foundations episode, we cover the essentials that are asked most: what lupus is, who gets it, why it's tricky to diagnose, how it's classified and worked up, what “typical treatment” looks like today, and what recent guidelines emphasize (think: steroid minimization and treat-to-target). Expect practical insights on assessment, patient education, vaccine timing, and safety monitoring—plus simple strategies to speed recognition and improve handoffs. ---Nurses may be able to complete an accredited CE activity featuring content from this podcast and earn CE hours provided from Elite Learning by Colibri Healthcare. For more information, click hereAlready an Elite Member? Login hereLearn more about CE Podcasts from Elite Learning by Colibri HealthcareView Episode TakeawaysView this podcast course on Elite LearningSeries: Unraveling Lupus
JAGDcast - der Podcast für Jäger und andere Naturliebhaber (Jagd)
Hier die Studie zu den schwarzen Timber Wölfen, die ihre schwarze Farbe tatsächlich durch die Rückkreuzung mit Haushunden erhalten haben https://doi.org/10.1093/molbev/msy031 und hier ein paar Studien zum Genfluss https://onlinelibrary.wiley.com/doi/10.1111/brv.12298?msockid=28d7c33b519566483b38d5e250ed67b4 https://www.nature.com/articles/s41598-019-55273-w und die hier schlägt die Brücke weiter nach Osten und hat spannende Infos zur Nahrung der dortigen Wölfe https://nsojournals.onlinelibrary.wiley.com/doi/epdf/10.1002/wlb3.01210 die Connectivität ist teilweise enorm. Es bleibt spannend zu sehen, was insbesondere die Grenzschutzmaßnahmen an der Ostgrenze Polens für Folgen haben werden. Nachtrag: Ich habe sie selber noch nicht gelesen, aber hier auch noch eine Studie, um deren Verlinkung mich Caro gebeten hat: https://www.researchgate.net/publication/350826130_How_the_west_was_won_genetic_reconstruction_of_rapid_wolf_recolonization_into_Germany's_anthropogenic_landscapes Happy reading. Werbung: JAGDcast wird Dir von Vortex Optics präsentiert. Mehr Infos zu den Produkten von Vortex findest Du unter www.vortexoptik.de
The Real Truth About Health Free 17 Day Live Online Conference Podcast
Dr. Goldner shares her powerful journey through a life-threatening lupus diagnosis, chemotherapy, and her resilience in pursuing medical school. #LupusSurvivor #AutoimmuneJourney #PatientToDoctor #ChronicIllness
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the transformative landscape of the industry, where scientific advancements, strategic corporate maneuvers, and regulatory shifts are paving new paths for drug development and patient care.Starting with Amgen's recent progress, the company has achieved a significant milestone with its phase 2 trial of daxdilimab for discoid lupus erythematosus. This breakthrough could mark a turning point in lupus treatment, a notoriously challenging area due to the disease's complexity and variability. The success of daxdilimab may lead to more targeted biologic therapies that improve outcomes for patients with limited options. Additionally, Amgen's decision to resist the FDA's request to withdraw Tavneos underscores the intricate dynamics of regulatory negotiations, especially for treatments addressing niche conditions with critical patient needs. This scenario exemplifies the challenges in balancing regulatory scrutiny with clinical efficacy and patient needs.Novo Nordisk continues to assert its position in the competitive landscape of metabolic disorder treatments. Despite Pfizer's acquisition of Metsera, Novo is steadfast in advancing GLP-1 therapies, particularly focusing on innovative formulations that enhance patient compliance and efficacy. Novo Nordisk is also focusing on its oral version of Wegovy amid market pressures. Despite analyst concerns about this strategy's sufficiency, Novo remains confident in stabilizing its market position. The oral formulation represents an important innovation in drug delivery systems, potentially enhancing patient compliance and expanding therapeutic reach. This determination reflects Novo's long-term strategy to lead in obesity treatments, an area where GLP-1 receptor agonists have shown substantial promise.In another significant development, Eli Lilly has reported remarkable financial performance driven by its GLP-1 receptor agonists Mounjaro and Zepbound. These drugs have propelled revenues to $11.7 billion in the fourth quarter, surpassing analyst expectations and highlighting the growing demand for GLP-1 therapies crucial in managing diabetes and obesity.In a push for innovation, the U.S. Department of Health and Human Services has launched a $100 million prize for developing broad-spectrum antiviral therapies. This initiative comes at a crucial time when global health challenges demand versatile therapeutic solutions capable of addressing various viral threats. The competition encourages novel approaches in antiviral drug development, potentially leading to breakthroughs that could revolutionize infectious disease management.GSK's new CEO, Luke Miels, is setting a strategic course by identifying mergers and acquisitions valued between $2 billion and $4 billion as "hidden in plain sight" opportunities. This strategy mirrors a broader industry trend where companies bolster their pipelines through acquisitions that complement existing portfolios and expedite market entry for innovative therapies.The National Institutes of Health faces its own set of challenges amidst public scrutiny. Director Jayanta Bhattacharya's public dismissal of any link between vaccines and autism represents a crucial step toward reaffirming public trust in vaccination programs. This statement is vital in dismantling pervasive myths contributing to vaccine hesitancy and reinforcing the scientific consensus on vaccine safety.PrimeGen's pursuit of a SPAC route to Nasdaq highlights evolving capital-raising strategies within biotech, especially as stem cell therapies emerge as promising treatments for various conditions. Securing adequate funding through innovative financial instruments is critical for advancing research from preclinical stages to clinical applications.BioNTech's multi-modality platformSupport the show
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of insightful updates that highlight the dynamic and rapidly evolving nature of these sectors, driven by scientific advancements, regulatory shifts, and strategic industry maneuvers.Starting with Merck, which is strategically planning for a post-Keytruda era, projecting over $70 billion in annual opportunities over the next decade. With Keytruda's patent expiration looming in 2028, Merck is actively expanding its portfolio through acquisitions and partnerships, focusing on oncology and immunology. These areas have been significantly impacted by Keytruda's success, and Merck's proactive approach aims to sustain growth and innovation beyond its current flagship product. During their 2025 full-year earnings call, CEO Robert Davis emphasized their expansive pipeline, highlighting recent strategic deals as pivotal to Merck's robust pipeline—the broadest it has been in years—signaling long-term growth through diversified therapeutic areas and innovative drug candidates.The U.S. Food and Drug Administration (FDA) is making waves with its regulatory approach to CAR-T cell therapies for autoimmune diseases. This shift reflects an increasing recognition of the potential these therapies hold for transforming treatment paradigms for conditions like lupus and multiple sclerosis. By offering a more flexible regulatory framework, the FDA is encouraging innovation while maintaining a focus on patient safety.In other regulatory news, AstraZeneca faces a setback with the FDA's rejection of its subcutaneous version of Saphnelo for lupus. The decision underscores the challenges associated with developing more patient-friendly administration methods for biologics. However, AstraZeneca remains optimistic about achieving a quick turnaround in the approval process, which could enhance patient adherence by offering a self-administered alternative to intravenous infusions.Sanofi finds itself in the spotlight after CEO Paul Hudson was sanctioned by the UK's Prescription Medicines Code of Practice Authority for making overly ambitious claims about Pfizer's RSV vaccine. This incident illustrates the competitive nature of vaccine procurement and underscores the importance of accurate communication by pharmaceutical leaders.In Massachusetts, Thermo Fisher Scientific is reducing its workforce with the closure of its Franklin site, impacting around 200 employees. This move is part of broader strategic realignments within the industry aimed at optimizing operations and focusing resources on high-growth areas.Acadia Pharmaceuticals faces potential rejection by the European Union for its drug trofinetide intended for Rett syndrome. This highlights ongoing challenges in gaining approval for treatments targeting rare diseases, despite their significant unmet needs.Meanwhile, GSK plans to lay off up to 350 R&D workers across the U.S. and UK as part of efforts to streamline operations and focus on core therapeutic areas. Such layoffs reflect broader industry trends toward consolidation and efficiency amid rising R&D costs.On a more promising note, Pfizer's GLP-1 receptor agonist has demonstrated significant results in a Phase 2b trial for weight loss, validating their substantial investment in this area. The drug's potential to offer competitive weight loss results with monthly dosing positions it as a strong contender in the obesity treatment market. Additionally, Pfizer continues to accelerate its efforts in obesity treatment with promising mid-stage trial results for PF-3944, showing up to a 12.3% weight loss at 28 weeks. This suggests Pfizer is keen on expanding its presence in obesity management through strategic clinical development as competition within this therapeutic area intensifies.The U.S. Department of Health and HumanSupport the show
Oral Manifestations of Lupus: A Dental Hygienist's Guide to Early Detection and ManagementBy Tanya L. Smith, RDH, BSOriginal article published on Today's RDH: https://www.todaysrdh.com/oral-manifestations-of-lupus-a-dental-hygienists-guide-to-early-detection-and-management/Need CE? Start earning CE credits today at https://rdh.tv/ce Get daily dental hygiene articles at https://www.todaysrdh.com Follow Today's RDH on Facebook: https://www.facebook.com/TodaysRDH/Follow Kara RDH on Facebook: https://www.facebook.com/DentalHygieneKaraRDH/Follow Kara RDH on Instagram: https://www.instagram.com/kara_rdh/
I've watched too many brilliant women struggle with weight despite doing everything "right.", so I asked Ashley Koff to join me and expose why the system has been rigged against us and reveals the real science behind the hormones that control our metabolism. Ashley shares her journey from "weight hot mess" to expert, explaining weight-health hormones like GLP-1, why your gut rules your entire ecosystem, and her revolutionary "deliciousness test" that fixes broken satiety signals. We dive into why 9 out of 10 Americans fail basic metabolic health tests, how GLP-1 agonists work as tools (not magic bullets), and why autoimmunity is really an operating system error. This conversation will change how you think about weight, health, and the tools available to support your body. For the complete show notes, links and transcripts, visit inspiredliving.show/229
Oral health is often treated as optional or cosmetic, but for people living with AiArthritis diseases, it can have a real impact on pain, fatigue, nutrition, and quality of life. In this episode, Leila and Bridget explore why oral health deserves a place in routine disease management and why so many patients are never told their symptoms are disease related. The episode looks at how autoimmune conditions and common medications can affect the mouth, from dry mouth and gum inflammation to delayed healing and increased infection risk. It also breaks down the connection between oral health, the immune system, and systemic inflammation, helping patients better understand why issues can show up even when oral hygiene is strong. Join us on this episode to hear practical, gentle strategies for protecting oral health when saliva is reduced or sensitivity is high. The discussion emphasizes adaptation over perfection and reinforces that oral health challenges are not personal failures, but part of living with complex chronic disease. Episode Highlights: Why oral health is often overlooked and why it matters in autoimmune disease How inflammation, medications, and reduced saliva affect the mouth The link between oral health and conditions like Sjögren's, rheumatoid arthritis, lupus, and scleroderma Gentle, realistic strategies to protect teeth and gums without causing more harm Links & Resources Go With Us! To ACR 2025: Oral Health: https://www.youtube.com/watch?v=q5XlwG4cNXo See more about co-existing conditions, disease management & more www.aiarthritis.org/patientjourney Have questions about this episode or topics you want to hear us bring to the table? Email us at podcast@aiarthritis.org Donate to Support the Show: www.aiarthritis.org/donate Follow AiArthritis on all social media platforms @IFAiArthritis Sign up for our Monthly AiArthritis Voices 360 Talk Show newsletter! HERE Connect with our Co-Hosts: Leila is the Health Education Manager at the International Foundation for AiArthritis. She is a person living with Lupus and Sjögren's disease. She is passionate about inclusion and diversity in health education and meeting individuals where they are at in order to learn in a way that resonates with them. Connect with Leila: Tiktok: @Lupuslifestyle.lei Bridget Dandaraw-Seritt founded a patient based organization that advocates for access to compassionate care and provides community support. She's a published author on therapeutic cannabis, presents at medical conferences, and is engaged in the policy making process. Connect with Bridget: Facebook: Advocates for Compassionate Therapy Now
Since this episode was released for the first time in May 2023, two recent studies of note have been published, providing an important update on patients' experiences of SLE in Latin America and Europe. These publications are summarisedbelow (full publications are available online):Study Summary:The Patient Experience of SLE in Latin AmericaQuintana R, et al. Living with systemic lupus erythematosus in 2024: Latin American experience based on a patient survey. Clin Rheumatol. 2025 Dec 5. doi: 10.1007/s10067-025-07867-1. This 2024 GLADEL network survey of 1,180 Latin American patients reveals a profound "well-being gap" in Systemic Lupus Erythematosus (SLE) care. While 80.9% receive antimalarials and two-thirds feel "controlled," clinical stability masks a pervasive psychosocial crisis. The data shows that 60% of patients suffer from anxiety or depression, and 62.1% report significant professional or educational setbacks. Physical burdens remain high, including joint involvement (71.4%), skin issues (47.4%), and life-altering renal complications (37.5%). Furthermore, 43.7% noted negative impacts on emotional and sexual health.Despite heavy reliance on corticosteroids (55.7%), uptake of newer biologics remains low at 11.1%. These findings serve asa critical call for Latin American healthcare systems to adopt a "Treat-to-Target" model. This approach must move beyond mere symptom management to prioritize the restoration of a patient's social, mental, and professional agency. Study Summary:Unmet Needs of SLE Patients in EuropeCornet A, et al. Experiences and unmet needs of persons living with systemic lupus erythematosus in Europe: LupusEurope's 2024 Swiss knife survey. Autoimmun Rev. 2025 Jul 31;24(8):103838. doi: 10.1016/j.autrev.2025.103838. The 2024 "Swiss Knife" survey by Lupus Europe reveals a significant "perception gap" among 4,525 patients across 36 countries. While 66.5% believe their lupus is "under control," only 7.9% remained flare-free over five years, indicating a normalization of chronic symptoms.Several unmet needs remain. The study found that fatigue is the most prevalent symptom (84.9%) but remains the least addressed in clinical plans. Joint and muscle pain also remain high. Patients seek remission or low disease activity, yet 32% lack access to essential non-pharmacological therapies like physiotherapy. Over 31% report insufficient consultation time, often leaving discontent unvoiced. Finaly, adoption of digital health tools remains low at 14.3%.The survey concludes that European SLE management must shift toward patient-centered care, prioritizing better physician-patient communication and digital health integration to address the disease's true physical and psychological burden.In this episode Dr Raquel Faria is speaking with Jeanette Andersen (Chair of Lupus Europe) and Professors Ricard Cervera and Maria Dall'Era.You can visit the Lupus Europe website here: https://www.lupus-europe.org/Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.'
Season SIX Episode FIVE of the Your Story Our Fight® podcast welcomes Linda Park. In this episode, we sit down with the multi-talented Linda Park. Known for her iconic roles in Star Trek: Enterprise and Bosch, and most recently seen in Peacock's The Paper and Netflix's A Man on the Inside, Linda has spent her career acting alongside industry greats. But behind the scenes, Linda has navigated a different journey: a lupus diagnosis at age eighteen.As an actress, dancer, and award-winning screenwriter, Linda shares the inspiration behind her new project, Edie (a story developed at the Sundance Collab) and her journey writing about her experiences with lupus. For Linda, storytelling became a vital way to process the complex reality of being a woman whose body is her art, her work, and her battleground.We are so proud to support Linda's mission to promote lupus awareness through evocative, authentic narrative storytelling.
In this episode of the Lupus Foundation of America's The Expert Series podcast, Dr. Cindy Aranow discusses the newly released American College of Rheumatology treatment guidelines for systemic lupus erythematosus (SLE). She explains the importance of these guidelines in providing evidence-based recommendations for individualized patient care, the process of developing and updating the guidelines and key changes that emphasize optimal disease control and reducing long-term steroid use. Dr. Aranow highlights the need for patient engagement and communication with health care providers to ensure effective management of lupus.This episode of The Expert Series was sponsored by AstraZeneca. The Lupus Foundation of America would like to thank AstraZeneca for their support of education programs for people with lupus.Sign up to receive emails from the Lupus Foundation of America (LFA) when new episodes are published: https://support.lupus.org/site/SPageNavigator/email_subscribe_expert_series.htmlEpisode Takeaways:Treatment guidelines are recommendations, not mandates, and support - not replace - your doctor's clinical judgment.Lupus is a highly individualized disease, so care must be tailored to each person.A diverse group of experts develops and regularly updates guidelines based on new research.Guidelines help clinicians navigate complex and evolving medical evidence.Recent guidelines emphasize achieving remission or low disease activity while reducing long-term steroid use.Open communication and active patient involvement are essential for effective treatment decisions. Related Resources:Ask a Lupus Health Educator (LFA): https://www.lupus.org/care-support/ask-a-health-educatorFind Support Near You (LFA): https://www.lupus.org/resources/find-support-near-youNational Resource Center on Lupus (LFA): https://www.lupus.org/resourcesThe Expert Series (LFA): https://www.lupus.org/resources/lupus-the-expert-seriesNew Lupus Treatment Guidelines (ACR): https://rheumatology.org/press-releases/new-lupus-sle-clinical-practice-guidelines-released
I'm excited to share my conversation with Julie Olson, who developed her game-changing HealthyHairFix protocol after experiencing severe hair loss herself. Julie breaks down her 5-R framework that addresses 76 different causes of hair loss through five functional categories. We dive into the surprising gut-hair connection, why biotin supplements might be working against you, and how hidden toxins like mercury fillings trigger hair loss. You'll discover why topical treatments can't fix internal problems and learn the lifestyle secrets Julie observed in Sardinia's blue zone. If you're dealing with hair loss, this episode offers hope and a clear roadmap for addressing root causes instead of just masking symptoms. For the complete show notes, links and transcripts, visit inspiredliving.show/228
What if you could detect early warning signs of serious health conditions in just minutes, from the comfort of your own home? Download Your Health Compass Assessment Tool: https://yourhealthcompass.org In this groundbreaking episode, longevity expert Lisa Tamati unveils the revolutionary Health Compass App - a privacy-focused wellness tool that empowers you to take control of your health destiny through evidence-based questionnaires and self-assessment. Forget expensive tests and lengthy doctor visits. This simple yet powerful app uses validated public health data to flag early indicators for conditions that matter most, putting the power of health awareness directly in your hands. In this episode, we explore: How the Health Compass App works: simple yes/no questionnaires based on symptoms and risk factors Early detection insights for Parkinson's, Diabetes, Alzheimer's, Cancer (Prostate & Breast), Multiple Sclerosis, Lupus, Asthma, Anxiety, and Depression Why privacy matters: non-personalised summaries that respect your data sovereignty The difference between empowering insights and medical diagnostics How this tool fits into your biohacking and peak performance toolkit Self-sovereign health: taking charge without compromising your privacy When and why to consult healthcare professionals based on your results The future of personalised health assessment technology Whether you're deep into biohacking, focused on peak performance, or simply want to stay ahead of potential health issues, this app becomes your companion for proactive, self-directed wellness. Lisa breaks down exactly how to use this tool effectively and why early awareness - not diagnosis - can be your most powerful health asset. Ready to take control of your health compass?
What if I told you that fibromyalgia and chronic fatigue aren't actually diseases, but symptoms of something hiding in plain sight? My guest today is Dr. Peter Osborne, known as "The Gluten Free Warrior," and he's about to blow your mind with what he's discovered about mold toxicity. If you've been struggling with autoimmune symptoms that won't budge despite making all the right diet changes, this episode might be the missing piece of your puzzle. Dr. Osborne breaks down the three distinct ways mold affects your health (hint: it's not just allergies), why those quick air tests are basically useless, and the shocking reality that at least 50% of buildings have water damage issues. We also dive into his six non-negotiable fundamentals for health that everyone needs to hear. This conversation could literally save your life or the life of someone you love. For the complete show notes, links and transcripts, visit inspiredliving.show/227
Season FIVE Episode FIVE of the Your Story Our Fight® podcast welcomes Shedrica Holmes. Shedrica is a lupus advocate, podcast host, and creator of the Chronically Planned platform. Diagnosed with lupus in 2008, she shares honest conversations around chronic illness, identity, faith, and rebuilding life through intentional planning. Through storytelling and guidance, Shedrica creates space for women living with lupus to feel seen, supported, and empowered to move forward at their own pace.
When a reproductive endocrinologist shrugs and says "unexplained infertility," it doesn't mean there's no answer - they're just looking in the wrong places. In this episode I'm talking with Dr. Susan Fox, a Traditional Chinese Medicine expert with 23 years of fertility experience, about how ancient medicine patterns can solve fertility challenges that conventional medicine can't explain. Susan's own unexplained autoimmune condition led her to discover TCM, and now she's revolutionized fertility care with an integrated approach that combines the best of Eastern and Western medicine. Her results? A 42% increase in live birth rates with her online program. We dive into the real causes behind fertility struggles - from environmental toxins like microplastics showing up in places they shouldn't be, to autoimmune factors that conventional testing completely misses. Plus, Susan shares practical strategies you can start today to support your fertility naturally. This is essential listening whether you're trying to conceive, supporting someone who is, or want to understand how modern life is affecting our reproductive health. For the complete show notes, links and transcripts, visit inspiredliving.show/226
Da sind wir wieder, neues Jahr neue Folge! Diesmal geht es um Kommentare, Venezuela, den Einbruch in der Sparkasse Gelsenkirchen, Ki Bilder, SpaceX, Dr. House, Uncharted, und KCD. Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte: https://linktr.ee/AlliterationAmArsch Du möchtest Werbung in diesem Podcast schalten? Dann erfahre hier mehr über die Werbemöglichkeiten bei Seven.One Audio: https://www.seven.one/portfolio/sevenone-audio
Nici Burns, founder of Nibu Naturals, a British skincare brand that helps women over 40 embrace pro-aging and feel confident in their skin with clean, handcrafted face serums.Through her small-batch, astaxanthin-powered formulations, Nici delivers visible results without compromising on ethics, safety, or sustainability.Now, Nici's journey of surviving Lupus, emotional abuse, and homelessness - then rebuilding her life from scratch at 53 - demonstrates fierce resilience and unwavering purpose.And while leading a growing brand that started at her kitchen table, she's proving that beauty, healing, and strength go far deeper than skin.Here's where to find more:https://nibunaturals.comhttps://www.instagram.com/nibu_naturals/profilecard/?igsh=dmph…________________________________________________Welcome to The Unforget Yourself Show where we use the power of woo and the proof of science to help you identify your blind spots, and get over your own bullshit so that you can do the fucking thing you ACTUALLY want to do!We're Mark and Katie, the founders of Unforget Yourself and the creators of the Unforget Yourself System and on this podcast, we're here to share REAL conversations about what goes on inside the heart and minds of those brave and crazy enough to start their own business. From the accidental entrepreneur to the laser-focused CEO, we find out how they got to where they are today, not by hearing the go-to story of their success, but talking about how we all have our own BS to deal with and it's through facing ourselves that we find a way to do the fucking thing.Along the way, we hope to show you that YOU are the most important asset in your business (and your life - duh!). Being a business owner is tough! With vulnerability and humor, we get to the real story behind their success and show you that you're not alone._____________________Find all our links to all the things like the socials, how to work with us and how to apply to be on the podcast here: https://linktr.ee/unforgetyourself
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today we're diving into a landscape rich with scientific advancements, strategic industry shifts, and regulatory developments that are shaping the future of healthcare.Let's start with AstraZeneca's recent success in the lupus treatment field. Their Phase 3 clinical trial for a self-administered subcutaneous form of Saphnelo marks a significant milestone. This new administration route could enhance patient convenience and accessibility, positioning AstraZeneca favorably against competitors like GlaxoSmithKline's Benlysta. The move underscores a growing trend in the industry towards more patient-friendly drug delivery systems, which could revolutionize treatment adherence and outcomes for autoimmune diseases.Turning our attention to Argenx, the company is navigating a pivotal leadership transition following the launch of Vyvgart, their autoimmune drug. This shift highlights the company's strong footing in the market after successfully obtaining regulatory approval and introducing Vyvgart. The potential expansion of its reach could further solidify Argenx's standing in the competitive autoimmune sector.Alumis is also making waves with its TYK2 inhibitor for psoriasis treatment, having reported promising Phase 3 data. This development places it as a formidable contender to Bristol Myers Squibb's Sotyktu. The positive trial results have not only boosted Alumis' stock value but also reflect a broader interest in immunomodulatory treatments which offer patients alternative therapeutic options with potentially fewer side effects.In an innovative leap within obesity management, Arrowhead Pharmaceuticals is advancing its dual gene-silencing assets aimed at reducing fat. Early-phase data indicates promising results, highlighting gene therapy's potential as a viable strategy for tackling complex conditions like obesity. This approach could pave the way for more personalized and effective treatments, aligning with the industry's gradual shift towards precision medicine.On the regulatory front, there's been notable movement with significant updates affecting drug approvals and recommendations. The Centers for Disease Control and Prevention's decision to remove six vaccines from the recommended childhood immunization schedule has stirred controversy due to its opaque review process. Such decisions carry profound implications for public health policies and vaccine uptake, sparking debates about safety and transparency.Meanwhile, GlaxoSmithKline's Exdensur has gained approval in Japan for two new indications, showcasing efforts to expand existing drugs' therapeutic applications across different markets. However, Sanofi has faced hurdles with the FDA rejecting its multiple sclerosis drug due to serious safety concerns, including liver injury risks. This rejection underscores the delicate balance regulatory bodies must maintain between efficacy and safety when evaluating new therapeutics.Amgen's strategic acquisition of a UK biotech firm for up to $840 million exemplifies ongoing industry consolidation trends. By integrating preclinical blood cancer programs into its portfolio, Amgen aims to strengthen its oncology pipeline—a critical area in today's competitive cancer treatment landscape. Similarly, Roche has strategically invested $100 million in a licensing deal with Structure Therapeutics to secure its position within the GLP-1 therapeutics sphere for metabolic disorders.These strategic acquisitions and partnerships highlight an industry focused on bolstering pipelines through external collaborations—essential for maintaining competitive edges in high-stakes therapeutic areas like oncology and metabolic disorders. As companies endeavor to innovate while ensuring safety, their efforts promise to enhance patient care by addressing unmet mSupport the show
I had the most fascinating conversation with Dr. Lé Santha Naidoo about something I see constantly in my practice: high-achieving women who've learned to "handle everything" but struggle to receive help—and how this pattern can literally make us sick. Dr. Naidoo is triple-board certified and author of "Fat to Fabulous," but what struck me most was her vulnerability in sharing her own healing journey. After losing a pregnancy in a car accident, she suffered 9 years of undiagnosed pain. When she finally had surgery, her community showed up in ways she never expected—and their support accelerated her healing more than any prescription could. We dive deep into how childhood trauma creates patterns that affect our health decades later, why purpose matters more than hormones for many symptoms, and how community support isn't just nice to have—it's essential medicine. If you've ever felt like you need to "have it all together," this conversation will challenge everything you think you know about strength and healing. For the complete show notes, links and transcripts, visit inspiredliving.show/225
What do you think of serrapeptase for reducing coronary plaque?We were told to get a TDAP vaccine or we wouldn't be able to see our new grandchild for 8 weeks!Do I have lupus?Which supplements tend to reduce negative effects of X-rays?
The Holiday Season in NYCPeanut allergies cause and effectWhich calcium supplements can I take if I'm allergic to cow protein?Can my husband take saw palmetto in lieu of his prostate medications?What do you think of traction to help bulging discs?What is your take on green powder supplements?
Are you pushing through chronic symptoms without pause? You'll want to listen to this episode!In it I sit down with Lisa Beth Lent, who transformed her health from complete dysfunction with Graves disease to sustained remission. Lisa shares the warning signs most of us ignore - from persistent headaches to that feeling of running on empty - and reveals how learning to truly listen to your body can prevent autoimmune breakdown. We explore practical nervous system regulation techniques, the power of stillness in our overstimulated world, and simple breathwork you can use anywhere. Lisa also discusses her experience with various healing modalities and explains why self-compassion is crucial for lasting recovery. This conversation offers hope and actionable guidance for anyone dealing with autoimmune conditions or recognizing they've been pushing through symptoms too long. For the complete show notes, links and transcripts, visit inspiredliving.show/224
Donar órganos, inmigración, el pastoreo tradicional, enfermedades como la Ela o el Lupus, la escuela social, los barrios olvidados, la libertad, la reinserción, Palestina, la situación de los temporeros y muchos temas más han sido los protagonistas de este año que termina. Este año En Primera Persona sigue con muchas realidades sociales por descubrir y visibilizar. Porque lo que no se conoce no existe y lo que no se explica no se comprende y aquí lo hacemos en primera persona desde el 2008.Escuchar audio
In this episode our host Dr Raquel Faria, together with Professors David Isenberg and Richard Furie, explore the first major update to the Lupus Treatment Guidelines in 25 years, highlighting aggressive steroid sparing, universal hydroxychloroquine use, and the revolutionary potential of CAR T-cell therapy. Discover how precision medicine is shifting the standard of care from broad immunosuppression to targeted, personalized recovery. Disclaimer: During Lupus Academy podcast episodes, participants may refer to off-label use of medicines for patients with lupus. Lupus Academy does not make anyrecommendations about using a medicine outside the terms of its approved license for use.
LOL with Racquel Lupus Out LoudTake a listen before you walk into that holiday party, pause. Check in with your body, set your exit plan, prep your boundaries, choose comfort, and protect your peace.Lupus warriors, show up how you can, leave when you need, and never apologize for choosing your health.Your peace is part of the plan. #lupusincolor #lolwithracquel #lupusoutloud
Womanhood Wellness is where functional medicine meets feminine wisdom—guiding you to balance hormones, awaken libido, and prepare for pregnancy with intention. Join today.What if the hardest part of trying to conceive isn't your body, but the silence around what you're actually feeling?In this episode, Dr. Leah sits down with Dr. Andrea Liner, a licensed clinical psychologist who specializes in reproductive mental health. She's also an IVF mama who navigated nearly four years of infertility, including misdiagnosis, two egg retrievals, and being told at 32 that she needed an egg donor.The trying to conceive journey brings up emotions most people don't know how to name, let alone process. Dr. Andrea walks through the mental traps that commonly keep couples stuck, the relationship dynamics that shift under pressure, and what actually helps when nothing is going according to plan.You'll Learn:[00:00] Introduction[02:60] Dr. Andrea's nearly four-year fertility journey[15:27] The mental toll on high-functioning achievers who can't muscle their way through infertility[17:44] How fertility struggles permeate every aspect of your daily life and identity[18:45] The existential questions that surface when you feel like a failure at what matters most[24:29] When sex becomes a chore rather than a fun activity that cultivates connection and brings new life into the world[27:13] The worst things people say and how to navigate relationships during infertility[37:34] First steps for navigating pregnancy loss[40:55] The shame of struggling in pregnancy when you fought so hard to conceiveConnect on a deeper level with Dr. Andrea by joining her mailing list.Find more from Dr. Andrea:Flux Psychology | WebsiteReproductive Psychology | InstagramFind more from Dr. Leah:Dr. Leah Gordon | InstagramDr. Leah Gordon | WebsiteWomanhood Wellness | WebsiteFind more from Dr. Morgan:Dr. Morgan MacDermott | InstagramDr. Morgan MacDermott | WebsiteUse code HEALTHYMOTHER and save 15% at RedmondFor 20% off your first order at Needed, use code HEALTHYMOTHERSave $260 at Lumebox, use code HEALTHYASAMOTHER
After 30 years in emergency medicine, Dr Newman learned a hard truth: She could save patients through their crisis, but they never actually got better. They'd leave with longer medication lists, only to return sicker. It wasn't until her own health crashed during menopause that she discovered cellular medicine - the missing piece that explains why we stay sick. In this conversation with Dr. Siobhan Newman, you'll discover why your mitochondria might be "underwater," her three dietary "nos" that are silently destroying your cellular health, and the recovery-first approach that must happen before any optimization. We dive deep into the inflammatory cascade, why COVID taught us so much about immune dysfunction, and practical steps you can take today to support true healing at the cellular level. If you're tired of managing symptoms instead of addressing root causes, this episode will change everything. For the complete show notes, links and transcripts, visit inspiredliving.show/223
TODAY ON THE ROBERT SCOTT BELL SHOW: HHS Overhauls Vaccine Schedule, Kennedy Targets Lyme Disease, Big Food Exposed, Cheese Protects Brain, Senega, Offit Avoids Debate, Food Dyes Harm Kids, Measles Strain Confusion, Most Dangerous States at Christmas, Lupus Remedies, and MORE! https://robertscottbell.com/hhs-overhauls-vaccine-schedule-kennedy-targets-lyme-disease-big-food-exposed-cheese-protects-brain-senega-offit-avoids-science-debate-food-dyes-harm-kids-measles-wild-or-vaccine-virus-most-da/https://boxcast.tv/view/hhs-overhauls-vaccine-schedule-kennedy-targets-lyme-big-food-exposed-offit-avoids-debate-lupus-remedies---the-rsb-show-12-19-25-d96x4k6zzmd6eef0lb2a Purpose and Character The use of copyrighted material on the website is for non-commercial, educational purposes, and is intended to provide benefit to the public through information, critique, teaching, scholarship, or research. Nature of Copyrighted Material Weensure that the copyrighted material used is for supplementary and illustrative purposes and that it contributes significantly to the user's understanding of the content in a non-detrimental way to the commercial value of the original content. Amount and Substantiality Our website uses only the necessary amount of copyrighted material to achieve the intended purpose and does not substitute for the original market of the copyrighted works. Effect on Market Value The use of copyrighted material on our website does not in any way diminish or affect the market value of the original work. We believe that our use constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the U.S. Copyright Law. If you believe that any content on the website violates your copyright, please contact us providing the necessary information, and we will take appropriate action to address your concern.
Hola!!En el episodio de hoy converso con Jorge Fragío, médico especialista en Reumatología y doctor en Medicina, para hablar con calma, rigor y claridad de un tema que genera muchas dudas y, a menudo, también miedo: las enfermedades autoinmunes. Cada vez escuchamos más hablar de lupus, artritis reumatoide, enfermedad de Behçet u otras patologías autoinmunes. Pero ¿realmente son más frecuentes o simplemente las diagnosticamos mejor? ¿Por qué el sistema inmune, que debería protegernos, empieza a atacar a nuestro propio cuerpo?En esta conversación intento preguntarle como medico y paciente de varias enfermedades autoinmunes, preguntas importantes como:– Por qué parece que las enfermedades autoinmunes están en aumento y qué parte se debe a un mejor diagnóstico.– Qué se sabe hoy sobre las causas de la autoinmunidad y por qué no existe una única explicación.– Lupus: síntomas iniciales que pueden pasar desapercibidos durante años.– Artritis reumatoide: más allá del dolor articular, qué otros órganos puede afectar y cómo se manifiesta esa afectación.– Enfermedad de Behçet: en qué consiste y por qué es tan difícil de diagnosticar.– El papel del estrés, la alimentación y el estilo de vida en la aparición y evolución de estas enfermedades.– Complementos y nutrientes con mayor evidencia como apoyo, como la vitamina D o los omega 3, siempre como parte de un abordaje médico integral. Un episodio para entender mejor la autoinmunidad, poner contexto, desmontar ideas erróneas y recordar que hoy contamos con más conocimiento, para saber mas, temer menos y elegir mejor. Para mi un episodio muy especial, ojala para vosotros, tambien lo sea y os sirva para quienes tenéis enfermedades autoinmunes o para entender mejor a personas de vuestro alrededor que las tengan Puedes seguir y aprender más de Jorge Fragío en Instagram: @drjorgefragioPara mas información ya sabéis que me tenéis en mi instagram @isabelvina dónde te comparto contenido diario Mi TikTok @isabelvinabasEn mi canal de YouTube Canal YoutubeY los suplementos formulados por mi en mi web Mi web
To have Dr. Morse answer a question, visit: https://drmorses.tv/ask/ Dr. Morse Q&A - Kidney Failure - Eye Damage - Rectal Cancer - Dizziness - Chronic Fatigue #816 00:00:00 - Intro - Filming Update - New Important Video 00:05:29 - Stage 4 Kidney Failure (Glomerulonephritis) 00:42:10 - Sun-gazing Eye Damage 00:47:15 - Stage 4 Rectal Cancer 01:00:40 - Young Athletes starting our journey to Wellville! 01:33:45 - Mold - Hypothyroid - Dizziness - Tinnitus - Hormonal Imbalance - Kidney Stones - Chronic Fatigue 00:05:29 - Stage 4 Kidney Failure (Glomerulonephritis) I was diagnosed late 2018 after a kidney biopsy, they thought I had Lupus to start with. 00:42:10 - Sun-gazing Eye Damage I have a translucent spot in the middle of my vision that appears to be spinning like a vortex. 00:47:15 - Stage 4 Rectal Cancer They wanted me to get surgery to possibly remove my rectum completely. 01:00:40 - Young Athletes starting our journey to Wellville! Are there other factors that take a toll, such as holding onto negative emotions? 01:33:45 - Mold - Hypothyroid - Dizziness - Tinnitus - Hormonal Imbalance - Kidney Stones - Chronic Fatigue I have 3 children, and after every child I thought I was dying.
At least 1.5 million people in the United States are living with lupus, a chronic and often misunderstood autoimmune disease. What are the most common myths about lupus – and who does it really affect? We spoke with Karen Costenbader, MD, MPH, director of the Lupus Program at Brigham and Women’s Hospital in Boston, about early symptoms to watch for, potential environmental triggers, widespread misconceptions, and what patients can expect from their healthcare team when seeking diagnosis and care.See omnystudio.com/listener for privacy information.
In this heartfelt episode, Dr. Isabelle Amigues sits down with her patient Elizabeth Anthony to discuss her journey from a high school lupus diagnosis and years of difficult symptoms, to finally finding answers and support at UnabridgedMD. Liz shares her struggles with medications, navigating the healthcare system, and the power of listening to her own intuition—even when others doubted her. Together, they explore what true partnership in care looks like, why feeling heard matters, and how hope and persistence can lead to real healing.If you or someone you love is feeling lost or unheard in their autoimmune journey, this conversation is for you. Subscribe for more patient stories, expert advice, and hope-driven science.#Lupus #AutoimmuneDisease #PatientStory #Rheumatology #Hope #ChronicIllness #UnabridgedMD #HealingJourney
Leslie Kenny is the CEO and founder of Oxford Healthspan, an innovative longevity company with a game-changing supplement called Primeadine. An Oxford-based longevity expert and Harvard alum, Leslie founded Oxford Healthspan after reversing her own Lupus, Rheumatoid Arthritis, and infertility and giving birth naturally at 43. Now 60, with a biological age of 21, she's committed to helping others optimize their health span. Leslie is also co-founder of the Oxford Longevity Project, a nonprofit dedicated to public education on aging smarter with science-backed strategies.
I used to think my clients just needed more willpower when they couldn't stick to their nutrition plans. Even as a registered dietitian, I struggled with this myself - having all the right information but still self-sabotaging my own health goals. In this episode, Gina Worful explains the real science behind why we lose control around food, and it has nothing to do with weakness. When stress hits, your brain shifts from logical decision-making to survival mode, making food taste better and shutting off fullness signals. You'll discover why your prefrontal cortex goes offline during stress, how to recognize early warning signs before cravings overwhelm you, and Gina's 3-step method to regulate your nervous system and make conscious food choices. This completely reframes self-sabotage as self-protection and teaches you to work with your body's natural responses. For the complete show notes, links and transcripts, visit inspiredliving.show/222
QD300: Flare or Beware (featuring Lindsay Tom, PA-C and Phong Nguyen, MD) QD301: CAR-T Cell Therapy for Lupus (featuring Philip Mease, MD and Cayla Alexander, DNP) QD302: Unweanable PMR (featuring Jack Cush, MD, and Leilani Law, APN) QD303: Weakness with Fibromyalgia (featuring Jack Cush, MD, and Leilani Law, APN)
Alarme é um quadro do canal Não Inviabilize. Aqui você ouve as suas histórias misturadas às minhas!Use a hashtag #Lupus e comente a história no nosso grupo do telegram: https://t.me/naoinviabilizePUBLICIDADE ASTRAZENECAAcesse o site amarcadacoragem.com.br e saiba mais sobre o Lúpus, seus sintomas, mitos e verdades. Ao sinal de sintomas, procure um médico, principalmente reumatologista. BR-46254-Novembro/2025. Material destinado ao público geral.QUER OUVIR MAIS HISTÓRIAS? BAIXE NOSSO APLICATIVO EM SUA LOJA APPLE/GOOGLE, CONHEÇA NOSSOS QUADROS EXCLUSIVOS E RECEBA EPISÓDIOS INÉDITOS DE SEGUNDA A QUINTA-FEIRA: https://naoinviabilize.com.br/assineEnvie a sua história bem detalhada para naoinviabilize@gmail.com, seu anonimato será mantido, todos os nomes, profissões e locais são trocados para preservar a sua identidade.Site: https://naoinviabilize.com.brTranscrição dos episódios: https://naoinviabilize.com.br/episodiosYoutube: https://youtube.com/naoinviabilizeInstagram: https://www.instagram.com/naoinviabilizeTikTok: https://www.tiktok.com/@naoinviabilizeX: https://x.com/naoinviabilizeFacebook: https://facebook.com/naoinviabilizeEdição de áudios: Depois O Leo Corta MultimídiaVinhetas: Pipoca SoundVoz da vinheta: Priscila Armani
Florida is set to execute its record breaking 17th inmate of the year. And while the guilt of 63-year-old Richard Barry Randolph is not in question, the method by which he will die tonight is, according to his attorneys. Randolph suffers from Lupus and believes dying by lethal injection will be cruel and unusual given his condition, which his lawyers claim will amplify any sensation of pain. He’s been on death row for more than 3 decades now for the rape and brutal murder of his former coworker, and even though his death sentence had a far from unanimous jury decision, he has officially exhausted all of his appeals.See omnystudio.com/listener for privacy information.
Florida is set to execute its record breaking 17th inmate of the year. And while the guilt of 63-year-old Richard Barry Randolph is not in question, the method by which he will die tonight is, according to his attorneys. Randolph suffers from Lupus and believes dying by lethal injection will be cruel and unusual given his condition, which his lawyers claim will amplify any sensation of pain. He’s been on death row for more than 3 decades now for the rape and brutal murder of his former coworker, and even though his death sentence had a far from unanimous jury decision, he has officially exhausted all of his appeals.See omnystudio.com/listener for privacy information.
Florida is set to execute its record breaking 17th inmate of the year. And while the guilt of 63-year-old Richard Barry Randolph is not in question, the method by which he will die tonight is, according to his attorneys. Randolph suffers from Lupus and believes dying by lethal injection will be cruel and unusual given his condition, which his lawyers claim will amplify any sensation of pain. He’s been on death row for more than 3 decades now for the rape and brutal murder of his former coworker, and even though his death sentence had a far from unanimous jury decision, he has officially exhausted all of his appeals.See omnystudio.com/listener for privacy information.